Silex Systems Limited, a technology commercialization company, engages in the research and development, commercialization, and license of SILEX laser enrichment technology in Australia, the United States, and the United Kingdom. The company operates in three segments: Silex Systems, Translucent, and Silex USA. The company sells its cREO technology; and develops its laser-based enrichment technology for use in various applications comprising uranium production and enrichment for nuclear power; silicon enrichment for silicon quantum computing; and medical isotope enrichment for new cancer therapies. Silex Systems Limited was incorporated in 1987 and is based in Sydney, Australia.